|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowance of $1,139 and $936 as of September 30, 2018 and December 31, 2017, respectively | ||||||||||||||||||||
| Deferred costs, current | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Insurance recoveries receivable | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Severance pay fund | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other assets including non-current deferred costs | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Income taxes | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Accrued and other current liabilities | ||||||||||||||||||||
| Accrued legal settlement | ||||||||||||||||||||
| Deferred revenue, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term accrued severance pay | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Commitments and contingencies (See note 7) | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY: | ||||||||||||||||||||
| Preferred stock, $0.0001 par value - 5,000,000 shares authorized, no shares issued and outstanding as of December 31, 2017 and 2016, respectively | ||||||||||||||||||||
| Common stock, $0.0001 par value - 145,000,000 shares authorized, 35,151,159 and 34,233,888 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
